UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Matrix metalloproteinases (MMPs) in bladder cancer: the induction of MMP9 by epidermal growth factor and its detection in urine

BJU international, 2003-01, Vol.91 (1), p.99-104

2003

Volltextzugriff (PDF)

The wide variation in response of mesothelioma cell lines to pemetrexed and lack of relationship to presence of folate receptor alpha (Fra)

Lung cancer (Amsterdam, Netherlands), 2009, Vol.63, p.S26-S26

2009

Volltextzugriff (PDF)

Expression of folate receptor alpha (FRa) in malignant pleural mesothelioma patients by immunohistochemistry: a clinico-pathological analysis

Lung cancer (Amsterdam, Netherlands), 2009, Vol.63, p.S27-S27

2009

Volltextzugriff (PDF)

Induction of metalloproteinase (MMP1) expression by epidermal growth factor (EGF) receptor stimulation and serum deprivation in human breast tumour cells

European journal of cancer (1990), 1996-11, Vol.32 (12), p.2127-2135

1996

Volltextzugriff (PDF)

Studies of human alkaline phosphatases by isoelectric focusing and electrophoresis

Nutt, J.E

1972

Volltextzugriff (PDF)

P.6.d.006 Effects of nicotinised and denicotinised cigarette smoking on response to 7.5% carbon dioxide anxiety challenge

European neuropsychopharmacology, 2010, Vol.20, p.S591-S591

2010

Volltextzugriff (PDF)

P.4.c.005 The cardiovascular effects of a subtype selective and non-selective benzodiazepine agonist in healthy volunteers

European neuropsychopharmacology, 2009, Vol.19, p.S606-S607

2009

Volltextzugriff (PDF)

P.4.c.009 Dose-dependent effects of a clinically effective and non-effective dose of lorazepam on 7.5% CO2-induced anxiety

European neuropsychopharmacology, 2009, Vol.19, p.S609-S609

2009

Volltextzugriff (PDF)

Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram

European neuropsychopharmacology, 2004-10, Vol.14 (5), p.367-372

2004

Volltextzugriff (PDF)

S.21.03 Can CO2 be used to model different anxiety disorders?

European neuropsychopharmacology, 2004-10, Vol.14, p.S153-S154

2004

Volltextzugriff (PDF)

P.4.e.006 Does the inhalation of CO2 activate neurosteroids in healthy participants? A pilot study

European neuropsychopharmacology, 2009, Vol.19, p.S615-S616

2009

Volltextzugriff (PDF)

P.1.43 The effects of C-cycloserine on a cognitive task under different states of anxiety

European neuropsychopharmacology, 2007, Vol.17, p.S37-S37

2007

Volltextzugriff (PDF)

P.4.e.003 The further development of a new model of GAD: I – the effects of single dose alprazolam and zolpidem

European neuropsychopharmacology, 2007, Vol.17, p.S521-S522

2007

Volltextzugriff (PDF)

P.4.e.001 The further development of a new model of GAD: II – The effects of single dose anxiolytic medication

European neuropsychopharmacology, 2007, Vol.17, p.S520-S521

2007

Volltextzugriff (PDF)

S.21.03 Can CO 2 be used to model different anxiety disorders?

European neuropsychopharmacology, 2004, Vol.14, p.S153-S154

2004

Volltextzugriff (PDF)

P.4.e.006 A pooled analysis of the effects of 7.5% CO2 inhalation in healthy participants: a useful model of human anxiety?

European neuropsychopharmacology, 2006-01, Vol.16, p.S474

2006

Volltextzugriff (PDF)

P.4.e.006 A pooled analysis of the effects of 7.5% CO 2 inhalation in healthy participants: a useful model of human anxiety?

European neuropsychopharmacology, 2006, Vol.16, p.S474-S474

2006

Volltextzugriff (PDF)

P.4.a.018 The effects of D-cycloserine on a cognitive function task under different states of anxiety in healthy volunteers

European neuropsychopharmacology, 2006, Vol.16, p.S457-S458

2006

Volltextzugriff (PDF)

P.4.c.003 Preliminary evidence of efficacy of a CRF1 receptor antagonist in the 7.5% CO2 model of anxiety

European neuropsychopharmacology, 2008, Vol.18, p.S494-S494

2008

Volltextzugriff (PDF)

P.4.e.002 The further development of a new model of GAD: no effect of 7.5% CO2 on HPA axis activation in healthy volunteers

European neuropsychopharmacology, 2007-10, Vol.17, p.S521-S521

2007

Volltextzugriff (PDF)

P.4.e.002 The further development of a new model of GAD: no effect of 7.5% CO 2 on HPA axis activation in healthy volunteers

European neuropsychopharmacology, 2007, Vol.17, p.S521-S521

2007

Volltextzugriff (PDF)

A comparison of the effects of sertraline and clomipramine on postural blood pressure changes and heart rate and blood pressure variability

European neuropsychopharmacology, 1994, Vol.4 (3), p.294-295

1994

Volltextzugriff (PDF)

Effects of fluvoxamine and clomipramine treatment on beat-by-beat changes in blood pressure during standing

European neuropsychopharmacology, 1993, Vol.3 (3), p.440-441

1993

Volltextzugriff (PDF)

Beat to beat monitoring of orthostatic hypotension — a comparison of phenelzine with moclobemide

European neuropsychopharmacology, 1993, Vol.3 (3), p.441-441

1993

Volltextzugriff (PDF)

Extensible parallel program performance visualization

MASCOTS '95. Proceedings of the Third International Workshop on Modeling, Analysis, and Simulation of Computer and Telecommunication Systems, 1995, p.205-211

1995

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(27)

Publikationsform

Sprache

Englisch
(28)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Psychiatry
(10)
Internal Medicine
(9)
Biological And Medical Sciences
(3)
Humans
(3)
Life Sciences & Biomedicine
(3)
Medical Sciences
(3)
Science & Technology
(3)
Antidepressant
(2)
Female
(2)
Hematology, Oncology And Palliative Medicine
(2)
Male
(2)
Pulmonary/respiratory
(2)
Tumor Cells, Cultured
(2)
Adrenergic Alpha-Antagonists - Metabolism
(1)
Adult
(1)
Animals
(1)
Antidepressant Drugs
(1)
Autonomic Nervous System
(1)
Bladder Cancer
(1)
Blood Pressure
(1)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Matrix metalloproteinases (MMPs) in bladder cancer: the induction of MMP9 by epidermal growth factor and its detection in urine

The wide variation in response of mesothelioma cell lines to pemetrexed and lack of relationship to presence of folate receptor alpha (Fra)

Expression of folate receptor alpha (FRa) in malignant pleural mesothelioma patients by immunohistochemistry: a clinico-pathological analysis

Induction of metalloproteinase (MMP1) expression by epidermal growth factor (EGF) receptor stimulation and serum deprivation in human breast tumour cells

Studies of human alkaline phosphatases by isoelectric focusing and electrophoresis

P.6.d.006 Effects of nicotinised and denicotinised cigarette smoking on response to 7.5% carbon dioxide anxiety challenge

P.4.c.005 The cardiovascular effects of a subtype selective and non-selective benzodiazepine agonist in healthy volunteers

P.4.c.009 Dose-dependent effects of a clinically effective and non-effective dose of lorazepam on 7.5% CO2-induced anxiety

Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram

S.21.03 Can CO2 be used to model different anxiety disorders?

P.4.e.006 Does the inhalation of CO2 activate neurosteroids in healthy participants? A pilot study

P.1.43 The effects of C-cycloserine on a cognitive task under different states of anxiety

P.4.e.003 The further development of a new model of GAD: I – the effects of single dose alprazolam and zolpidem

P.4.e.001 The further development of a new model of GAD: II – The effects of single dose anxiolytic medication

S.21.03 Can CO 2 be used to model different anxiety disorders?

P.4.e.006 A pooled analysis of the effects of 7.5% CO2 inhalation in healthy participants: a useful model of human anxiety?

P.4.e.006 A pooled analysis of the effects of 7.5% CO 2 inhalation in healthy participants: a useful model of human anxiety?

P.4.a.018 The effects of D-cycloserine on a cognitive function task under different states of anxiety in healthy volunteers

P.4.c.003 Preliminary evidence of efficacy of a CRF1 receptor antagonist in the 7.5% CO2 model of anxiety

P.4.e.002 The further development of a new model of GAD: no effect of 7.5% CO2 on HPA axis activation in healthy volunteers

P.4.e.002 The further development of a new model of GAD: no effect of 7.5% CO 2 on HPA axis activation in healthy volunteers

A comparison of the effects of sertraline and clomipramine on postural blood pressure changes and heart rate and blood pressure variability

Effects of fluvoxamine and clomipramine treatment on beat-by-beat changes in blood pressure during standing

Beat to beat monitoring of orthostatic hypotension — a comparison of phenelzine with moclobemide

Extensible parallel program performance visualization

Suchergebnisse filtern